User profiles for "author:Edward H Wood"

Edward H Wood

Vitreoretinal Surgeon, Innovator, Researcher, Educator
Verified email at austinretina.com
Cited by 598

Nondamaging retinal laser therapy for treatment of central serous chorioretinopathy: what is the evidence?

EH Wood, PA Karth, SR Sanislo, DM Moshfeghi… - Retina, 2017 - journals.lww.com
Purpose: To summarize the literature addressing subthreshold or nondamaging retinal laser
therapy (NRT) for central serous chorioretinopathy (CSCR) and to discuss results and trends …

STEM CELL THERAPIES, GENE-BASED THERAPIES, OPTOGENETICS, AND RETINAL PROSTHETICS:: Current State and Implications for the Future

EH Wood, PH Tang, I De la Huerta, E Korot, S Muscat… - Retina, 2019 - journals.lww.com
Purpose: To review and discuss current innovations and future implications of promising
biotechnology and biomedical offerings in the field of retina. We focus on therapies that have …

[HTML][HTML] 80 Years of vision: preventing blindness from retinopathy of prematurity

EH Wood, EY Chang, K Beck, BR Hadfield… - Journal of …, 2021 - nature.com
Retinopathy of prematurity (ROP) is one of the leading yet preventable causes of childhood
blindness worldwide. The purpose of this review is to provide a practical template for …

The impact of prefilled syringes on endophthalmitis following intravitreal injection of ranibizumab

PP Storey, Z Tauqeer, Y Yonekawa, B Todorich… - American journal of …, 2019 - Elsevier
Purpose To compare the rates of infectious endophthalmitis following intravitreal injection of
ranibizumab using prefilled syringes vs conventional preparation. Design Multicenter …

Visual acuity measured with a smartphone app is more accurate than Snellen testing by emergency department providers

AS Pathipati, EH Wood, CK Lam, CS Sáles… - Graefe's archive for …, 2016 - Springer
Purpose To assess the accuracy of best-corrected visual acuity (BCVA) measured by non-
ophthalmic emergency department (ED) staff with a standard Snellen chart versus an …

Short-term outcomes of aflibercept therapy for diabetic macular edema in patients with incomplete response to ranibizumab and/or bevacizumab

EH Wood, PA Karth, DM Moshfeghi… - … Surgery, Lasers and …, 2015 - journals.healio.com
BACKGROUND AND OBJECTIVE: Aflibercept is a vascular endothelial growth factor (VEGF)
inhibitor recently approved by the US Food and Drug Administration for the treatment of …

[PDF][PDF] Retinopathy of prematurity treatment trends from 2003 to 2020 in the United States

SI Khan, WY Ryu, EH Wood, DM Moshfeghi, JK Shah… - Ophthalmology, 2022 - Elsevier
We used population-based data obtained from Optum's Clinformatics® Data Mart Database
to characterize recent trends in retinopathy of prematurity (ROP) treatments and outcomes in …

The natural history of congenital X-linked retinoschisis and conversion between phenotypes over time

EH Wood, I Lertjirachai, BK Ghiam, N Koulisis… - Ophthalmology …, 2019 - Elsevier
Purpose To evaluate the natural history of congenital X-linked retinoschisis (CXLRS) and to
assess disease stability or progression over time. Design Retrospective case series at a …

Correlating changes in the macular microvasculature and capillary network to peripheral vascular pathologic features in familial exudative vitreoretinopathy

N Koulisis, SN Moysidis, Y Yonekawa, YL Dai… - Ophthalmology …, 2019 - Elsevier
Purpose To evaluate the macular microvasculature in patients with familial exudative
vitreoretinopathy (FEVR) using OCT angiography (OCTA) and to assess for peripheral …

[HTML][HTML] The present and future of mitochondrial-based therapeutics for eye disease

MH Ji, A Kreymerman, K Belle… - … Vision Science & …, 2021 - tvst.arvojournals.org
Mitochondrial dysfunction within the eye contributes to primarily mitochondrial diseases
affecting the visual system such as Leber hereditary optic neuropathy (LHON) as well as …